Archives mensuelles :

décembre 2019

Victor Moreau rejoint Dianosic comme ingénieur R&D

Victor Moreau rejoint Dianosic comme ingénieur R&D 540 250 Philippe Bastide

Victor Moreau rejoint Dianosic comme ingénieur R&D pour accompagner le développement de sa solution innovante dans le traitement de la sinusite chronique


Dianosic is committed to the development of disruptive technologies in the field of Ear Nose and Throat (ENT) and focuses more specifically on the nasal cavity. As we pursue our efforts to bring our disruptive solution to life in the field of #chronicsinusitis, we are glad to announce that Victor Moreau is joining the team as R&D Engineer.

Victor brings a solid knowledge in the formulation of resorbable polymers for biomedical applications. Victor also worked as a Quality Assistant at DEDIENNE SANTE. Those competencies will greatly contribute to the progress of our project. Victor, along with Sarah Zahouani (CTO, Dianosic) will work closely with the Polymers for Health and Biomaterials team, which has a renowned expertise in bioresorbable polymers. We’d like to thank Xavier Garric (Head of the, PHBM), the CNRS – Centre national de la recherche scientifique, the Université de Montpellier and the ENSCM for making this fantastic partnership, in which Victor will have a central position, a reality.

We look forward to having this team transform the way patients with chronic sinusitis will be treated in the future and pave the way for Dianosic upcoming successes.


Victor, a warm welcome to you!


Jacques Penicaud soutient Dianosic

Jacques Penicaud soutient Dianosic 540 250 Philippe Bastide

Jacques Penicaud soutient Dianosic en vue du lancement de son premier produit CAVI-T dans les saignements intranasaux (épistaxis)


As dianosic continues to make headway towards commercialization of its CAVI-T solution in intranasal bleeding, we are excited to inform you that Jacques PENICAUD will support us in preparing the launch of this innovative product. 

During his career, Jacques held different positions at Johnson & Johnson ranging from Financial controler to Sales Director and Business Unit Director for the Medical Devices segment (Advanced Wound Care, Ethicon Biosurgery, Mitek and Advanced Sterilization Products). Jacques then pursued an external opportunity as the CEO of STERIENCE (sterilization business) before joining Abbott Vascular as General Manager. 

Jacques will leverage his huge experience in the successful launch of disruptive medical technologies to strategize commercialization efforts for our CAVI-T solution. 

Jacques, we look forward to disrupting the market together!! ????

#epistaxis #nosebleeds #ENT



Isabelle Perez accompagne Dianosic

Isabelle Perez accompagne Dianosic 540 250 Philippe Bastide

Isabelle Perez accompagne Dianosic dans le développement d’outils de formation innovants à destination des professionnels de santé


We are thrilled to announce you that Isabelle Perez will support dianosic in its venture and help us prepare the upcoming commercialization of our CAVI-T device in intranasal bleeding.

During her tenure at Johnson & Johnson and LivaNova, Isabelle developed state of the art Professional Education strategies and tools. By ensuring proper training of healthcare professionals and promoting the optimal use of our technology, Isabelle will be a great contributor to our upcoming successes.


Welcome aboard Isabelle ???